← Back to Search

Exercise Intervention for Young Cancer Survivors

N/A

Recruiting

Research Sponsored by Indiana University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age ≥ 15 and ≤ 39 years

History of cancer

Must not have

History of CNS tumor

Evidence of significant liver dysfunction, congestive heart failure, cardiovascular disease

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, weeks 6, 12, and 24

Awards & highlights

Summary

This trial will test the feasibility of a 12-week, individualized, prescribed, supervised exercise intervention in adolescent and young adult (AYA) cancer survivors.

Who is the study for?

This trial is for young cancer survivors aged 15-39 who finished chemotherapy at least three months ago. It's not for those with CNS tumors, Down's Syndrome, serious liver issues, heart failure, cardiovascular disease, or certain physical disabilities that prevent exercise.Check my eligibility

What is being tested?

The study tests a supervised exercise program tailored to individual needs of adolescent and young adult cancer survivors. The goal is to see if this improves their overall health and emotional well-being compared to typical outcomes without such intervention.See study design

What are the potential side effects?

Exercise programs are generally safe but can include muscle soreness, fatigue, and risk of injury if not properly supervised or if the participant overexerts themselves.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 15 and 39 years old.

Select...

I have had cancer in the past.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have had a brain or spinal cord tumor.

Select...

I do not have severe liver problems, heart failure, or heart disease.

Select...

I cannot do exercises like walking or lifting weights due to physical limitations.

Select...

I have a neurological disorder.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, weeks 6, 12, and 24

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, weeks 6, 12, and 24

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, weeks 6, 12, and 24 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change of Balance Assessment

Change of Cancer Therapy Fatigue

Change of Cardiovascular Systems - FCV

+8 more

Secondary outcome measures

Adverse Event Pain Assessment

Beck Anxiety Inventory

Depression - BDI

+5 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: ExerciseExperimental Treatment1 Intervention

Group II: Usual CareActive Control1 Intervention

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Exercise

2016

Completed Phase 1

~760

0 / 6Eligibility criteria met

Find a Location

Who is running the clinical trial?

Indiana UniversityLead Sponsor

997 Previous Clinical Trials

1,095,528 Total Patients Enrolled

Media Library

Exercise Clinical Trial Eligibility Overview. Trial Name: NCT04265638 — N/A

Pediatric Cancer Research Study Groups: Exercise, Usual Care

Pediatric Cancer Clinical Trial 2023: Exercise Highlights & Side Effects. Trial Name: NCT04265638 — N/A

Exercise 2023 Treatment Timeline for Medical Study. Trial Name: NCT04265638 — N/A

~11 spots leftby Jul 2025

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.